Jiří Vítovec

3.3k total citations
157 papers, 1.1k citations indexed

About

Jiří Vítovec is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Jiří Vítovec has authored 157 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Cardiology and Cardiovascular Medicine, 25 papers in Endocrinology, Diabetes and Metabolism and 22 papers in Surgery. Recurrent topics in Jiří Vítovec's work include Heart Failure Treatment and Management (53 papers), Cardiovascular Function and Risk Factors (38 papers) and Cardiac pacing and defibrillation studies (17 papers). Jiří Vítovec is often cited by papers focused on Heart Failure Treatment and Management (53 papers), Cardiovascular Function and Risk Factors (38 papers) and Cardiac pacing and defibrillation studies (17 papers). Jiří Vítovec collaborates with scholars based in Czechia, France and United States. Jiří Vítovec's co-authors include Jindřich Špinar, Lenka Špinarová, Ladislav Dušek, Jaroslav Meluzı́n, Jan Krejčí, Jiří Jarkovský, Jindřich Špinar, Petr Hude, Filip Málek and Lenka Špinarová and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and CHEST Journal.

In The Last Decade

Jiří Vítovec

122 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiří Vítovec Czechia 16 815 192 178 133 104 157 1.1k
A.A. Voors Netherlands 14 1.1k 1.4× 332 1.7× 157 0.9× 163 1.2× 139 1.3× 22 1.5k
Khawaja Afzal Ammar United States 13 779 1.0× 129 0.7× 211 1.2× 64 0.5× 138 1.3× 69 1.0k
Marco Gorini Italy 17 1.7k 2.1× 150 0.8× 250 1.4× 153 1.2× 106 1.0× 59 2.1k
Silvia Bugatti Italy 17 997 1.2× 365 1.9× 123 0.7× 96 0.7× 120 1.2× 32 1.2k
Alessandro Boccanelli Italy 20 1.1k 1.3× 145 0.8× 360 2.0× 156 1.2× 118 1.1× 82 1.4k
Marco Comeglio Italy 14 541 0.7× 105 0.5× 210 1.2× 93 0.7× 89 0.9× 37 934
Ildikó Amann-Zalán Germany 9 1.2k 1.4× 149 0.8× 148 0.8× 216 1.6× 84 0.8× 15 1.4k
M Huelsmann Austria 18 1.2k 1.5× 278 1.4× 265 1.5× 152 1.1× 153 1.5× 48 1.4k
Catherine N. Marti United States 13 709 0.9× 118 0.6× 98 0.6× 104 0.8× 54 0.5× 24 982

Countries citing papers authored by Jiří Vítovec

Since Specialization
Citations

This map shows the geographic impact of Jiří Vítovec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Vítovec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Vítovec more than expected).

Fields of papers citing papers by Jiří Vítovec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiří Vítovec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Vítovec. The network helps show where Jiří Vítovec may publish in the future.

Co-authorship network of co-authors of Jiří Vítovec

This figure shows the co-authorship network connecting the top 25 collaborators of Jiří Vítovec. A scholar is included among the top collaborators of Jiří Vítovec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiří Vítovec. Jiří Vítovec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vítovec, Jiří, et al.. (2024). Betablockers and CV disease - controversy 2023. 38(1). 5–8.
2.
3.
4.
Špinar, Jindřich, Lenka Špinarová, & Jiří Vítovec. (2018). Pathophysiology, causes and epidemiology of chronic heart failure. Vnitřní lékařství. 64(9). 834–838. 29 indexed citations
5.
Vítovec, Jiří, Jindřich Špinar, & Lenka Špinarová. (2018). Arrhythmias and conductance disturbances and heart failure. Vnitřní lékařství. 64(9). 874–877. 1 indexed citations
6.
Vítovec, Jiří, Lenka Špinarová, & Jindřich Špinar. (2018). Comorbidities in heart failure. Vnitřní lékařství. 64(9). 867–873. 1 indexed citations
7.
8.
Krejčí, Jan, Petr Hude, Tomáš Freiberger, et al.. (2013). Impact of inflammatory infiltration and viral genome presence in myocardium on the changes of echocardiographic parameters. Cor et Vasa. 55(4). e333–e340. 8 indexed citations
9.
Honĕk, T, Jan Krejčí, Lenka Špinarová, et al.. (2012). Heart transplantation for cardiac light chain amyloidosis with subsequent autologous stem cell transplantation. Cor et Vasa. 55(5). e468–e473. 1 indexed citations
10.
Vítovec, Jiří, Lenka Špinarová, & Jindřich Špinar. (2011). Sekundární prevence po infarktu myokardu - režimové a farmakologické postupy. Interní medicína pro praxi. 13(5). 202–204. 2 indexed citations
11.
Lipoldová, Jolana, et al.. (2010). USEFULNESS OF LEFT VENTRICLE DYSSYNCHRONY ASSESSMENT BEFORE CARDIAC RESYNCHRONIZATION IMPLANTATION. Biomedical Papers. 154(1). 39–46. 3 indexed citations
12.
Špinar, Jindřich, Jiří Vítovec, & Lenka Špinarová. (2008). The TIMI trials - 25 years of clinical research (1984-2009). Cor et Vasa. 50(12). 480–485. 1 indexed citations
13.
Špinar, Jindřich & Jiří Vítovec. (2007). Levosimendan mění indikace i dávkování. Cor et Vasa. 49(3). 1 indexed citations
14.
Špinar, Jindřich, et al.. (2007). Doporučení pro diagnostiku a léčbu srdečního selhání ČKS 2006. Cor et Vasa. 49(1). 1 indexed citations
15.
Špinarová, Lenka, Jindřich Špinar, Anna Vašků, et al.. (2007). Is humoral activation in heart failure affected by a genetic predisposition?. Cor et Vasa. 49(4). 127–133. 1 indexed citations
16.
Špinar, Jindřich & Jiří Vítovec. (2006). Co by měl internista vědět o diastolickém srdečním selhání. Interní medicína pro praxi. 7(12). 527–532.
17.
Vítovec, Jiří & Jindřich Špinar. (2005). VALIANT - Valsartan, captopril nebo obojí u infarktu myokardu komplikovaného srdečním selháním a/nebo dysfunkcí levé komory - samostatně ano, společně ne. 18(1). 53–54. 1 indexed citations
18.
Dobšák, Petr, et al.. (2004). IMPROVEMENT OF MUSCULAR PERFORMANCE IN PATIENTS WITH CHRONICHEART FAILURE AFTER SOME WEEKS OF LOW-FREQUENCY ELECTRICALSTIMULATION. 77. 1 indexed citations
19.
Vítovec, Jiří & Jindřich Špinar. (2003). Mohou blokátory receptorů pro angiotenzin II (AIIA) nahradit vléčbě srdečního selhání inhibitory ACE. Cor et Vasa. 2 indexed citations
20.
Vítovec, Jiří & Jindřich Špinar. (2003). Který betablokátor u srdečního selhání?Studie COMET - dalajasnou odpověď?. Cor et Vasa. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.A. Voors Breakdown of academic impact, for papers by Khawaja Afzal Ammar Breakdown of academic impact, for papers by Marco Gorini Breakdown of academic impact, for papers by Silvia Bugatti Breakdown of academic impact, for papers by Alessandro Boccanelli Breakdown of academic impact, for papers by Marco Comeglio Breakdown of academic impact, for papers by Ildikó Amann-Zalán Breakdown of academic impact, for papers by M Huelsmann Breakdown of academic impact, for papers by Catherine N. Marti
Rankless by CCL
2026